
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic support of tumour-infiltrating regulatory T cells by lactic acid
McLane J. Watson, Paolo Vignali, Steven J. Mullett, et al.
Nature (2021) Vol. 591, Iss. 7851, pp. 645-651
Open Access | Times Cited: 796
McLane J. Watson, Paolo Vignali, Steven J. Mullett, et al.
Nature (2021) Vol. 591, Iss. 7851, pp. 645-651
Open Access | Times Cited: 796
Showing 1-25 of 796 citing articles:
Lactate metabolism in human health and disease
Xiaolu Li, Yanyan Yang, Bei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 648
Xiaolu Li, Yanyan Yang, Bei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 648
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Lukas Kraehenbuehl, Chien‐Huan Weng, Shabnam Eghbali, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 37-50
Closed Access | Times Cited: 588
Lukas Kraehenbuehl, Chien‐Huan Weng, Shabnam Eghbali, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 37-50
Closed Access | Times Cited: 588
CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4
Peng Liao, Weimin Wang, Weichao Wang, et al.
Cancer Cell (2022) Vol. 40, Iss. 4, pp. 365-378.e6
Open Access | Times Cited: 529
Peng Liao, Weimin Wang, Weichao Wang, et al.
Cancer Cell (2022) Vol. 40, Iss. 4, pp. 365-378.e6
Open Access | Times Cited: 529
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
Shogo Kumagai, Shohei Koyama, Kota Itahashi, et al.
Cancer Cell (2022) Vol. 40, Iss. 2, pp. 201-218.e9
Open Access | Times Cited: 518
Shogo Kumagai, Shohei Koyama, Kota Itahashi, et al.
Cancer Cell (2022) Vol. 40, Iss. 2, pp. 201-218.e9
Open Access | Times Cited: 518
Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells
Jia Xiong, Jia He, Jun Zhu, et al.
Molecular Cell (2022) Vol. 82, Iss. 9, pp. 1660-1677.e10
Open Access | Times Cited: 410
Jia Xiong, Jia He, Jun Zhu, et al.
Molecular Cell (2022) Vol. 82, Iss. 9, pp. 1660-1677.e10
Open Access | Times Cited: 410
A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance
Alexander C. Huang, Roberta Zappasodi
Nature Immunology (2022) Vol. 23, Iss. 5, pp. 660-670
Open Access | Times Cited: 389
Alexander C. Huang, Roberta Zappasodi
Nature Immunology (2022) Vol. 23, Iss. 5, pp. 660-670
Open Access | Times Cited: 389
Metabolic barriers to cancer immunotherapy
Kristin DePeaux, Greg M. Delgoffe
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 785-797
Open Access | Times Cited: 384
Kristin DePeaux, Greg M. Delgoffe
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 785-797
Open Access | Times Cited: 384
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 382
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 382
T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 367
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 367
Therapeutic targeting of the hypoxic tumour microenvironment
Dean C. Singleton, Andrew Macann, William R. Wilson
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 751-772
Closed Access | Times Cited: 334
Dean C. Singleton, Andrew Macann, William R. Wilson
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 751-772
Closed Access | Times Cited: 334
Turning cold tumors hot: from molecular mechanisms to clinical applications
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 324
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 324
Lactate in the tumour microenvironment: From immune modulation to therapy
Zi-Hao Wang, Wenbei Peng, Pei Zhang, et al.
EBioMedicine (2021) Vol. 73, pp. 103627-103627
Open Access | Times Cited: 276
Zi-Hao Wang, Wenbei Peng, Pei Zhang, et al.
EBioMedicine (2021) Vol. 73, pp. 103627-103627
Open Access | Times Cited: 276
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Seong Keun Kim, Sun Wook Cho
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 268
Seong Keun Kim, Sun Wook Cho
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 268
Metabolic programming and immune suppression in the tumor microenvironment
Emily N. Arner, Jeffrey C. Rathmell
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 421-433
Open Access | Times Cited: 265
Emily N. Arner, Jeffrey C. Rathmell
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 421-433
Open Access | Times Cited: 265
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
Christopher Tay, Atsushi Tanaka, Shimon Sakaguchi
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 450-465
Open Access | Times Cited: 263
Christopher Tay, Atsushi Tanaka, Shimon Sakaguchi
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 450-465
Open Access | Times Cited: 263
Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer
Macus Hao‐Ran Bao, Carmen Chak‐Lui Wong
Cells (2021) Vol. 10, Iss. 7, pp. 1715-1715
Open Access | Times Cited: 230
Macus Hao‐Ran Bao, Carmen Chak‐Lui Wong
Cells (2021) Vol. 10, Iss. 7, pp. 1715-1715
Open Access | Times Cited: 230
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
Qiang Feng, Zhida Liu, Xuexin Yu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 220
Qiang Feng, Zhida Liu, Xuexin Yu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 220
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Shohei Koyama, Hiroyoshi Nishikawa
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002591-e002591
Open Access | Times Cited: 219
Shohei Koyama, Hiroyoshi Nishikawa
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002591-e002591
Open Access | Times Cited: 219
Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells
Jian Gu, Jinren Zhou, Qiuyang Chen, et al.
Cell Reports (2022) Vol. 39, Iss. 12, pp. 110986-110986
Open Access | Times Cited: 218
Jian Gu, Jinren Zhou, Qiuyang Chen, et al.
Cell Reports (2022) Vol. 39, Iss. 12, pp. 110986-110986
Open Access | Times Cited: 218
Tumour burden and efficacy of immune-checkpoint inhibitors
Filippo Gustavo Dall’Olio, Aurélien Marabelle, Caroline Caramella, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 2, pp. 75-90
Closed Access | Times Cited: 216
Filippo Gustavo Dall’Olio, Aurélien Marabelle, Caroline Caramella, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 2, pp. 75-90
Closed Access | Times Cited: 216
Neutrophil phenotypes and functions in cancer: A consensus statement
Daniela F. Quail, Borko Amulic, Monowar Aziz, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 213
Daniela F. Quail, Borko Amulic, Monowar Aziz, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 213
Metabolic adaptation of lymphocytes in immunity and disease
Nicole M. Chapman, Hongbo Chi
Immunity (2022) Vol. 55, Iss. 1, pp. 14-30
Open Access | Times Cited: 187
Nicole M. Chapman, Hongbo Chi
Immunity (2022) Vol. 55, Iss. 1, pp. 14-30
Open Access | Times Cited: 187
Metabolic communication in the tumour–immune microenvironment
Kung‐Chi Kao, Stefania Vilbois, Chin‐Hsien Tsai, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 11, pp. 1574-1583
Closed Access | Times Cited: 178
Kung‐Chi Kao, Stefania Vilbois, Chin‐Hsien Tsai, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 11, pp. 1574-1583
Closed Access | Times Cited: 178
CD8+ T cells in the cancer-immunity cycle
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 168
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 168
Modulating Glycolysis to Improve Cancer Therapy
Chaithanya Chelakkot, Vipin Shankar Chelakkot, Young Kee Shin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2606-2606
Open Access | Times Cited: 167
Chaithanya Chelakkot, Vipin Shankar Chelakkot, Young Kee Shin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2606-2606
Open Access | Times Cited: 167